World-Class Speaker Faculty

Speakers

Expand/Collapse

Alejandro Rangel
Applied Neurosciences Department Head
Mexican Council of Neuroscience

Day One

Tuesday, April 19, 2022

11:45 am | Narrowing the Gap to Diagnose Alzheimer’s Disease Through Biomarkers

Andrea Crotti
Principal Scientist
Takeda Pharmaceutical

Day Two

Wednesday, April 20, 2022

12:00 pm | Microglial Emerging Therapies & Targets under Clinical Trial for Neurodegenerative & Neuropsychiatric Disorders

10:00 am | Panel Discussion: Targets for Neuroinflammation

Andrew Koemeter-Cox
Associate Director
The Michael J Fox Foundation for Parkinson’s Disease

Day One

Tuesday, April 19, 2022

11:15 am | Examining the Scope Inflammation Biomarkers for Parkinson’s Disease to Determine Effectivity

Brenda Moore
Research Assistant Professor
University of Florida

Day One

Tuesday, April 19, 2022

2:45 pm | Immunomodulation of Tau Pathology in Organotypic Brain Slice Cultures

Christopher Barnum
Head of Neuroscience
Inmune Bio

Day One

Tuesday, April 19, 2022

4:15 pm | Approaching Clinical Trials Targeting the Immune System: Understanding Biomarker Selection & Treatment Responses

Dimitry Ofengeim
Head of Precision Neurology & Neuroinflammation
Sanofi Genzyme

Day Two

Wednesday, April 20, 2022

1:30 pm | Analyzing the Role of Microglia in Neuroinflammatory Responses in MS: Insights from BTK

Dong Seok Kim
Chief Executive Officer
Aevis Bio

Pre-Conference Workshop Day

Monday, April 18, 2022

4:00 pm | Workshop D: Delving into the Role of Neuroinflammation in Traumatic Brain Injury (TBI)

Francisco Javier Quintana
Professor of Neurology; Associate Member
Ann Romney Centre for Neurologic Diseases Brigham & Women’s Hospital; Harvard Medicine School; The Broad Institute

Day Two

Wednesday, April 20, 2022

3:10 pm | Astrocytes as Therapeutic Targets in Neurologic Diseases

Hung-Kai (Kevin) Chen
Chairman & Chief Executive Officer
Elixiron Immunotherapeutics

Day Two

Wednesday, April 20, 2022

9:30 am | Utilizing Small Molecular Inhibitors to Target & Reduce Neuroinflammation

Jennifer Barnett
Chief Executive Officer
Monument Therapeutics

Day One

Tuesday, April 19, 2022

9:00 am | Using Digital Biomarkers to Apply a Stratified Approach to Neuroinflammation

Jesse Cedarbaum
Acting Chief Medical Officer
ImmnuoBrain Checkpoint

Day One

Tuesday, April 19, 2022

3:45 pm | Therapeutics for Neurodegenerative Disease – Cutting All 3 Legs

8:30 am | Opening Panel Discussion: What’s New in Neuroimmunology Drug Development?

Johan Luthman
Executive Vice President & Head of R&D
Lundbeck A/S

Day Two

Wednesday, April 20, 2022

10:00 am | Panel Discussion: Targets for Neuroinflammation

8:30 am | Using Classic Neuroimmunological Targets & Applying them to Different Neuroimmunology Indications

Johannes Grosse
Senior Director of Drug Discovery
Vir Biotechnology

Pre-Conference Workshop Day

Monday, April 18, 2022

11:00 am | Workshop B: Examining the Role of Genetics in Neuroinflammation & Neurodegenerative Disease

Julie Huang
Senior Scientist, Biomarker Sciences
Alector

Day One

Tuesday, April 19, 2022

12:15 pm | Utilizing Inflammatory Biomarkers to Assess the Activity of a Novel Therapeutic in Frontotemporal Dementia Patients with Granulin Mutation

Kuti Baruch
Head of R&D
ImmunoBrain Checkpoint

Day Two

Wednesday, April 20, 2022

11:30 am | Targeting the Peripheral Immune System as a Novel Therapeutic Approach in Alzheimer’s Disease

10:00 am | Panel Discussion: Targets for Neuroinflammation

LuLin Jiang
Staff Scientist
Sanford Burnham Prebys Medical Discovery Institute

Day Two

Wednesday, April 20, 2022

3:40 pm | The Role of Astrocytic Protein Homeostasis in Regulating Neuroinflammation & Neurodegeneration in AD

Malu Tansey
Professor of Neuroscience & Neurology; Co-Director
University of Florida College of Medicine; Centre for Translational Research in Neurodegenerative Disease

Day One

Tuesday, April 19, 2022

1:45 pm | Using Preclinical Models to Inform Clinical Trial Design Targeting Chronic Inflammation in Neurodegenerative Disease

Marianthi Papakosta
Head of In Vitro Neuroinflammation Pharmacology, Cell Protection Unit & Neuroscience
Takeda Pharmaceuticals

Day One

Tuesday, April 19, 2022

2:15 pm | Analyzing In Vitro Models of Microglia in Relation to Inflammasomes

8:30 am | Opening Panel Discussion: What’s New in Neuroimmunology Drug Development?

Mark Treherne
Chairman
Talisman Therapeutics

Day Two

Wednesday, April 20, 2022

9:00 am | The Pivotal Role of Glia in Neuroinflammation

Michael Mingueneau
Director of Research
Biogen

Day Two

Wednesday, April 20, 2022

11:00 am | Leveraging Well-Understood Peripheral Immune Targets to Advance our Understanding of Microglial Biology in the CNS

10:00 am | Panel Discussion: Targets for Neuroinflammation

Mike Nagle
Senior Director, Head of Neurogenomics
Eisai

Pre-Conference Workshop Day

Monday, April 18, 2022

11:00 am | Workshop B: Examining the Role of Genetics in Neuroinflammation & Neurodegenerative Disease

Nikhil Sharma
Founder & Chief Executive Officer
BioCortex

Pre-Conference Workshop Day

Monday, April 18, 2022

1:30 pm | Workshop C: Exploring the Role of the Gut-Brain Axis in Neuroinflammation

Olivia Corradin
Assistant Professor of Biology
MIT

Pre-Conference Workshop Day

Monday, April 18, 2022

11:00 am | Workshop B: Examining the Role of Genetics in Neuroinflammation & Neurodegenerative Disease

Paul Ashton
Chief Executive Officer & President
Inflammasome Therapeutics

Day One

Tuesday, April 19, 2022

4:45 pm | Novel Inflammasome Inhibitors: From Basic Research to Early Clinical

Richard Wyse
Director of R&D
The Cure Parkinson’s Trust

Day One

Tuesday, April 19, 2022

8:20 am | Chair’s Opening Remarks

Stan Chamberlain
Chief Scientific Officer
T3D Therapeutics

Day One

Tuesday, April 19, 2022

9:30 am | Monitoring Inflammatory & Metabolic Biomarkers in Phase 2 Clinical Trials of the Brain Penetrant Transcriptional Activator T3D-95

8:30 am | Opening Panel Discussion: What’s New in Neuroimmunology Drug Development?

Stanley Appel
Co-Director
Houston Methodist Neurological Institute; Advisory Board Chair COYA Therapeutics

Day One

Tuesday, April 19, 2022

8:30 am | Opening Panel Discussion: What’s New in Neuroimmunology Drug Development?

Day Two

Wednesday, April 20, 2022

2:00 pm | Suppressing Neuroinflammation: T-REG Cell Therapy of ALS

Thomas Nieland
Director & Head of Target Validation & Exploratory Biology
Verge Genomics

Pre-Conference Workshop Day

Monday, April 18, 2022

8:30 am | Workshop A: Deep-Dive into the Use of iPSC-Derived Cells Models to Measure Neuroinflammation in Neurodegeneration

Yung-Chih (Inge) Cheng
Principal Scientist
Pfizer

Pre-Conference Workshop Day

Monday, April 18, 2022

8:30 am | Workshop A: Deep-Dive into the Use of iPSC-Derived Cells Models to Measure Neuroinflammation in Neurodegeneration